O'Neill Institute
State Action to Lower Prescription Drug Prices: Navigating Patent PreemptionPrescription Drug Affordability Boards
Issue Metadata
More Prescription Drug Affordability tracked topics
-
Price Gouging Laws
Cases Tracked: 6
-
Orange Book Patent Listings
Cases Tracked: 4
-
Product Specific Access Laws
Cases Tracked: 4
-
Transparency Laws
Cases Tracked: 2
Important Date
Defendants' Response to Motion for Preliminary Injunction Due
Dive Deeper
O'Neill Institute
Pharmaceutical Industry Seeks to Thwart State Initiatives to Tackle Unaffordability of Prescription DrugsMore Issues
- 340B Program 15 cases
- Affordable Care Act 67 cases 6 Topics
- Anticompetitive Practices 19 cases
- Artificial Intelligence 3 cases
- Consumer Protections 11 cases
- Cost Containment 12 cases
- Equity 50 cases 1 Topics
- ERISA 15 cases
- Federal Health Funding 33 cases 4 Topics
- Health Information 2 cases
- Medicare Advantage 4 cases
- Medicare Drug Price Negotiation 20 cases
- No Surprises Act 35 cases 4 Topics
- Reproductive Health 42 cases 5 Topics
- Site-Neutral Payments 9 cases
- Transparency 5 cases